LABELLA

Medicinal product

(Invented) name

LABELLA

Active substance (s)

Levonorgestrelis

Strength

1,5 mg

Pharmaceutical form

tabletė

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AD01, Levonorgestrel

Marketing authorisation holder

UAB Actiofarma, Lietuva

Date of authorisation

2018-08-06

Date of renewal

Documents

0717_Labella_PZPL_2018-08-06.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Levonorgestrelis	1,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99916	86024	1086024	lizdinė plokštelė	N1		Nereceptinis	LT/L/18/0717/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2018-08-06	Registruotas